Definium Therapeutics Announces New Employee Inducement Grants (opens original article in a new tab)

Definium Therapeutics announced inducement grants of 155,480 stock options to six new employees with vesting schedules and exercise prices tied to June 2026 share prices.

• Definium Therapeutics issued 155,480 stock options to six new non-executive employees
• Options have exercise price equal to June 15, 2026 closing share price and vest over four years
• Grants were approved by Compensation Committee under NASDAQ Rule 5635(c)(4)